This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm.

The attorneys and staff here at The Michael Brady Lynch Firm are seeing more and more inquiries every day concerning birth defects and the anti-depressant Pristiq. This is an alarming trend, but not surprising.
Pristiq is an antidepressant with a similar pharmacological profile to Effexor. It was approved by the FDA in February 2008. The manufacturer, Wyeth, has plans to seek approval to market Pristiq as the first non-hormonal treatment for menopause.

Of note, the European Union had serious concerns over the safety and efficacy profile of Pristiq and refused approval of the drug. Although these concerns were not directly related to birth defects and Pristiq, the refusal is a telling indication of the problems associated with the drug here in the US.

Much like Effexor and the association with serious birth defects, there is growing scientific evidence that use of Pristiq is associated with cleft lip and cleft palate, as well as heart defects, club foot, and other birth defects.

If you or someone you know has taken Pristiq during pregnancy and given birth to a child with a birth defect such as cleft lip and cleft palate, club foot, a heart defect and or other birth defects, please contact me directly for a free, no-obligation evaluation of your claim.

About the Firm: The Michael Brady Lynch Firm is a trial firm with a focus on pharmaceutical mass tort cases involving SSRI and Anti-Seizure Medication Birth Defects such as Lexapro, Zoloft, Effexor, Prozac, Celexa, Paxil, Depakote and Topamax, as well as Actos Bladder Cancer and Fosamax Femur Fractures, and medical device cases including DePuy Hip and Trans-Vaginal Mesh cases. Contact us today if you or someone you know has experienced side effects involving these products.